BSE Live
Dec 31, 16:01Prev. Close
1104.65
Open Price
1110.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Key Financial Ratios of Kwality Pharmaceuticals (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 8.02 | 7.28 | 4.38 | 6.48 | 3.10 | |
| Diluted EPS (Rs.) | 8.02 | 7.28 | 4.38 | 6.48 | 3.10 | |
| Cash EPS (Rs.) | 12.18 | 10.29 | 7.13 | 11.15 | 5.93 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 42.56 | 34.23 | 27.72 | 48.35 | 42.62 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 43.33 | 35.00 | 27.72 | 48.35 | 42.62 | |
| Revenue from Operations/Share (Rs.) | 134.25 | 160.26 | 132.51 | 189.50 | 148.11 | |
| PBDIT/Share (Rs.) | 17.20 | 15.72 | 12.01 | 19.34 | 10.70 | |
| PBIT/Share (Rs.) | 12.93 | 12.72 | 9.14 | 14.51 | 7.32 | |
| PBT/Share (Rs.) | 10.52 | 10.51 | 7.03 | 10.89 | 4.94 | |
| Net Profit/Share (Rs.) | 7.91 | 7.28 | 4.26 | 6.32 | 2.56 | |
| NP After MI And SOA / Share (Rs.) | 8.02 | 7.28 | 4.38 | 6.48 | 3.10 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 12.81 | 9.80 | 9.06 | 10.20 | 7.22 | |
| PBIT Margin (%) | 9.63 | 7.93 | 6.89 | 7.65 | 4.94 | |
| PBT Margin (%) | 7.83 | 6.56 | 5.30 | 5.74 | 3.33 | |
| Net Profit Margin (%) | 5.89 | 4.54 | 3.21 | 3.33 | 1.72 | |
| NP After MI And SOA Margin (%) | 5.97 | 4.54 | 3.30 | 3.42 | 2.09 | |
| Return on Networth/Equity (%) | 18.39 | 20.69 | 15.28 | 13.14 | 7.14 | |
| Return on Capital Employed (%) | 20.65 | 29.61 | 27.70 | 25.66 | 14.87 | |
| Return on Assets (%) | 6.26 | 7.16 | 4.72 | 4.74 | 3.03 | |
| Total Debt/Equity (X) | 0.69 | 0.72 | 0.88 | 0.72 | 0.57 | |
| Asset Turnover Ratio (%) | 104.97 | 157.80 | 142.92 | 138.62 | 144.87 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.31 | 1.24 | 1.21 | 1.28 | 1.44 | |
| Quick Ratio (X) | 0.98 | 1.05 | 0.97 | 0.94 | 1.05 | |
| Inventory Turnover Ratio (X) | 6.21 | 14.79 | 9.15 | 7.10 | 7.17 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 9.25 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 5.30 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 90.75 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 94.70 | 0.00 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 5.37 | 5.78 | 4.33 | 4.01 | 3.08 | |
| Interest Coverage Ratios (Post Tax) (%) | 5.37 | 5.78 | 4.33 | 4.01 | 3.08 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 55.35 | 62.38 | 65.98 | 64.71 | 0.00 | |
| EV/Net Operating Revenue (X) | 0.40 | 0.38 | 0.48 | 0.66 | 0.00 | |
| EV/EBITDA (X) | 3.10 | 3.82 | 5.29 | 6.45 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.19 | 0.23 | 0.31 | 0.51 | 0.00 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 90.74 | 0.00 | |
| Price/BV (X) | 0.59 | 1.05 | 1.43 | 1.95 | 0.00 | |
| Price/Net Operating Revenue | 0.19 | 0.23 | 0.31 | 0.51 | 0.00 | |
| Earnings Yield | 0.31 | 0.20 | 0.11 | 0.07 | 0.00 |
04.12.2025
Kwality Pharmac Consolidated September 2025 Net Sales at Rs 111.05 crore, up 23.34% Y-o-Y
27.11.2025
Kwality Pharmac Standalone September 2025 Net Sales at Rs 111.31 crore, up 23.63% Y-o-Y
08.09.2025
Kwality Pharmac Standalone June 2025 Net Sales at Rs 111.48 crore, up 39.21% Y-o-Y
20.05.2025
Kwality Pharmac Consolidated March 2025 Net Sales at Rs 115.68 crore, up 25.77% Y-o-Y
04.12.2025
Kwality Pharmac Consolidated September 2025 Net Sales at Rs 111.05 crore, up 23.34% Y-o-Y
27.11.2025
Kwality Pharmac Standalone September 2025 Net Sales at Rs 111.31 crore, up 23.63% Y-o-Y
08.09.2025
Kwality Pharmac Standalone June 2025 Net Sales at Rs 111.48 crore, up 39.21% Y-o-Y
20.05.2025
Kwality Pharmac Consolidated March 2025 Net Sales at Rs 115.68 crore, up 25.77% Y-o-Y